A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece
NCT ID: NCT01215305
Last Updated: 2011-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2010-10-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
NCT00914342
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms
NCT01020890
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
NCT01635959
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
NCT00768443
National Survey on GERD Patients (Adults and Children)
NCT00833573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Visiting outpatient departments, if symtoms
patients with upper GI symptoms, visiting the outpatient departments of peripheral hospitals in Greece
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged 18 and over
* Patients with upper-GI symptoms during the last week prior to the study visit
Exclusion Criteria
* Patients with history of malignancy
* Treatment with acetylsalicylic acid/NSAID during the last week prior to the study visit
* Therapy with PPI for the healing of ulcer induced by treatment with acetylsalicylic acid/NSAID
* Therapy with PPI for HP eradication or for healing of HP-related peptic ulcer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca S.A. Greece
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Panagiotis Pontikis
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Chania, Crete, Greece
Research Site
Rhodes, Dodekanis, Greece
Research Site
Ioannina, Ipiros, Greece
Research Site
Preveza, Ipiros, Greece
Research Site
Áno Sýros, Kyklades, Greece
Research Site
Chalkidiki, Makedonia, Greece
Research Site
Edessa, Makedonia, Greece
Research Site
Kavala, Makedonia, Greece
Research Site
Serres, Makedonia, Greece
Research Site
Limnos, NE Aegian, Greece
Research Site
Kalamata, Peloponisos, Greece
Research Site
Kalávryta, Peloponisos, Greece
Research Site
Moláoi, Peloponisos, Greece
Research Site
Sparti, Peloponisos, Greece
Research Site
Karditsa, Thesalia, Greece
Research Site
Larissa, Thesalia, Greece
Research Site
Trikala, Thesalia, Greece
Research Site
Volos, Thesalia, Greece
Research Site
Komotini, Thraki, Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GGR-DUM-2010/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.